Profile data is unavailable for this security.
About the company
Glycorex Transplantation publ AB is a Sweden-based medical device company engaged in the research, development, production and sales of medical devices within the field of organ transplantation. The Company's main product, Glycosorb-ABO, facilitates organ transplantation between different blood types. Additionally, the Company has developed complementary product variants, such as Glycosorb-ABO A/B-kolonn, designed for different patient categories, and Glycosorb-Xeno, which can facilitate transplants between animals and humans. As of December 31, 2011, Glycosorb-ABO was used in 103 transplantation centers in 22 countries. As of December 31, 2011, the Company had four wholly owned subsidiaries, namely Glycoprobe AB, Glycorex Transplantation, Glycorex UMC AB and Glycorex UBP AB.
- Revenue in SEK (TTM)29.96m
- Net income in SEK-30.36m
- Incorporated1995
- Employees23.00
- LocationGlycorex Transplantation AB (publ)Scheelevagen 27LUND 223 63SwedenSWE
- Phone+46 462865230
- Fax+46 462865239
- Websitehttps://glycorex.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scandinavian ChemoTech AB | 2.82m | -21.09m | 37.29m | 6.00 | -- | 3.72 | -- | 13.22 | -1.58 | -1.58 | 0.2094 | 0.615 | 0.1543 | 0.3265 | 5.75 | 470,333.30 | -115.35 | -87.29 | -168.57 | -118.55 | 58.75 | 252.05 | -747.38 | -2,122.77 | 0.8244 | -23.70 | 0.00 | -- | 496.62 | 19.13 | 7.28 | -- | -- | -- |
| VibroSense Dynamics AB | 2.08m | -7.61m | 39.81m | -- | -- | 3.97 | -- | 19.17 | -0.5156 | -0.5156 | 0.1325 | 0.292 | 0.1889 | 0.1441 | 9.78 | -- | -69.18 | -46.24 | -85.81 | -53.08 | 94.02 | 85.61 | -366.26 | -551.22 | 3.09 | -- | 0.00 | -- | 22.89 | 29.61 | 6.88 | -- | -5.74 | -- |
| Scandinavian Real Heart AB | 902.89k | -67.98m | 41.03m | 11.00 | -- | 0.5001 | -- | 45.44 | -0.7008 | -0.7008 | 0.0105 | 0.8458 | 0.0081 | -- | 0.6595 | 82,080.91 | -61.12 | -24.27 | -72.47 | -26.81 | -60.31 | 491.13 | -7,528.86 | -3,241.65 | -- | -- | 0.0914 | -- | 35.24 | 51.98 | -385.97 | -- | 1.91 | -- |
| SciBase Holding AB (publ) | 23.25m | -55.59m | 46.73m | 27.00 | -- | 0.835 | -- | 2.01 | -0.5854 | -0.5854 | 0.2418 | 0.3593 | 0.4072 | 0.7503 | 2.89 | 860,962.90 | -97.36 | -68.63 | -143.11 | -87.77 | 69.00 | 61.28 | -239.12 | -300.20 | 2.56 | -32.77 | -- | -- | 29.93 | 27.50 | -28.75 | -- | 5.15 | -- |
| iZafe Group AB | 5.00m | -32.78m | 55.50m | 7.00 | -- | 2.81 | -- | 11.09 | -0.1614 | -0.1614 | 0.0216 | 0.0791 | 0.109 | 1.24 | 2.46 | -- | -71.38 | -52.17 | -82.09 | -69.40 | -10.99 | -- | -655.02 | -487.50 | 0.6947 | -- | 0.1174 | -- | 149.93 | -24.79 | -36.76 | -- | -- | -- |
| Inhalation Sciences Sweden AB | 17.50m | -4.74m | 61.13m | 8.00 | -- | 4.72 | -- | 3.49 | -0.3575 | -0.3575 | 1.37 | 0.8541 | 1.12 | 0.9465 | 5.42 | 2,188,000.00 | -30.46 | -27.93 | -43.51 | -43.82 | 79.77 | 71.13 | -27.10 | -48.02 | 2.63 | -3.80 | 0.0776 | -- | 43.55 | 26.33 | 60.87 | -- | -- | -- |
| Kontigo Care AB | 28.95m | 211.00k | 63.21m | 10.00 | 235.90 | 2.06 | 15.50 | 2.18 | 0.0098 | 0.0098 | 1.20 | 1.12 | 0.7134 | -- | 7.15 | -- | 0.52 | -0.4214 | 0.7563 | -0.6195 | 66.93 | 66.31 | 0.7289 | -0.5205 | -- | 1.73 | 0.1069 | -- | 1.80 | 16.95 | -92.68 | -- | 44.94 | -- |
| Glycorex Transplantation AB (publ) | 29.96m | -30.36m | 67.76m | 23.00 | -- | 1.61 | -- | 2.26 | -0.4111 | -0.4111 | 0.4057 | 0.5963 | 0.3701 | 0.3414 | -- | 1,302,696.00 | -37.50 | -11.30 | -46.16 | -13.17 | 89.63 | 91.60 | -101.34 | -33.24 | 1.36 | -182.38 | 0.207 | -- | -17.04 | -2.15 | -254.06 | -- | -0.5593 | -- |
| ProstaLund AB | 22.21m | -17.01m | 88.84m | -- | -- | 1.61 | -- | 4.00 | -0.2469 | -0.2469 | 0.3237 | 0.7219 | 0.3811 | 0.5004 | 8.84 | -- | -29.19 | -29.15 | -34.28 | -35.01 | 70.49 | 75.26 | -76.61 | -68.94 | 2.16 | -105.99 | 0.0235 | -- | 27.54 | 10.36 | -53.27 | -- | 20.35 | -- |
| BBS-Bioactive Bone Substitutes Oyj | 0.00 | -40.68m | 90.53m | -- | -- | 1.44 | -- | -- | -0.2926 | -0.2926 | 0.00 | 0.2647 | 0.00 | -- | -- | -- | -32.71 | -25.12 | -38.23 | -28.54 | -- | -- | -- | -- | -- | -28.79 | 0.482 | -- | -- | -- | -12.64 | -- | -- | -- |
| Luxbright AB | -466.64k | -23.07m | 92.68m | -- | -- | 1.97 | -- | -- | -0.3717 | -0.3717 | -0.0068 | 0.5101 | -0.0103 | -- | -- | -- | -50.99 | -52.69 | -53.38 | -60.37 | -- | -- | -- | -2,130.96 | -- | -- | 0.0044 | -- | 67.10 | -- | 38.77 | -- | -- | -- |
| Observe Medical ASA | -99.99bn | -99.99bn | 93.43m | -- | -- | 0.3557 | -- | -- | -- | -- | -- | 1.38 | -- | -- | -- | -- | -- | -31.10 | -- | -51.60 | -- | 33.76 | -- | -274.82 | 0.0711 | -- | 0.3526 | -- | -18.80 | 150.54 | -93.01 | -- | 25.73 | -- |
| Redsense Medical AB (publ) | 24.97m | -4.51m | 96.32m | 5.00 | -- | 4.17 | -- | 3.86 | -0.3214 | -0.3214 | 1.78 | 1.64 | 0.8724 | 8.18 | 6.32 | 4,993,400.00 | -15.77 | -18.66 | -17.96 | -20.99 | 52.70 | 69.02 | -18.08 | -46.28 | 3.49 | -- | 0.00 | -- | 74.11 | 28.94 | 48.47 | -- | -23.62 | -- |
| ScandiDos AB | 65.08m | -4.85m | 98.06m | 34.00 | -- | 2.27 | -- | 1.51 | -0.1063 | -0.1063 | 1.43 | 0.7588 | 0.9573 | 0.4787 | 7.39 | -- | -7.14 | -13.82 | -13.39 | -23.95 | 82.54 | 82.49 | -7.45 | -17.09 | 0.4511 | -2.63 | 0.00 | -- | 6.70 | 4.01 | -24.27 | -- | 4.18 | -- |
Data as of May 10 2024. Currency figures normalised to Glycorex Transplantation AB (publ)'s reporting currency: Swedish Krona SEK
4.17%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Skandia Fonder ABas of 31 Dec 2022 | 1.50m | 2.12% |
| Coeli Asset Management ABas of 31 Dec 2022 | 740.48k | 1.05% |
| Stena Finance ABas of 31 Dec 2022 | 708.31k | 1.00% |
| Evli Fund Management Co. Ltd.as of 28 Mar 2024 | 3.00k | 0.00% |
More ▼
Data from 28 Nov 2023 - 03 May 2024Source: FactSet Research Systems Inc.
